Celgene Hit With Suit For Blocking Generic Cancer Drugs
The City of Providence is leading a putative class of consumers who accuse Celgene Corp. in a New Jersey federal suit filed Tuesday of monopolizing the market for two blockbuster cancer...To view the full article, register now.
Already a subscriber? Click here to view full article